ESR1 and cancer: Interestingly, E2 was also able to trigger a differential landscape of miRNAs in GPER1 positive and ER-negative CAFs derived from primary and metastatic breast tumors [7], suggesting a fine regulation of miRNA expression by GPER in very different cancer microenvironments.